one aim hiv vaccine elicit neutral antibody nab limit replica gene diver virus prevent establish new infect thu identify strength weak early stage natur could prove use achieve goal demons viral escape readily occur despite develop high tier autolog two subject acuteearli subtype c provide detail portray pathway resist variant identify multiple time point use create semi envelope env glycoprotein camera mutant within background correspond newly transmit subject driven predominantly chang region gp extend begin v domain end vv howe social time require cooper ectodomain second depend pathway retain until reflect virus bail distinct monoclonal mab derive patient via introduce single potent link glycol site spatial represent sequence suggest select pressure act upon region even though domain drove differ together find argue mutant suffice confer support model strategy include glycol shift direct alter editor cooper conform mask eva neutral 